<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29099059</article-id>
<article-id pub-id-type="pmc">5713281</article-id>
<article-id pub-id-type="doi">10.3390/ijms18112312</article-id>
<article-id pub-id-type="publisher-id">ijms-18-02312</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Numakawa</surname>
<given-names>Tadahiro</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-18-02312">1</xref>
<xref ref-type="aff" rid="af2-ijms-18-02312">2</xref>
<xref ref-type="corresp" rid="c1-ijms-18-02312">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Odaka</surname>
<given-names>Haruki</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-18-02312">1</xref>
<xref ref-type="aff" rid="af3-ijms-18-02312">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adachi</surname>
<given-names>Naoki</given-names>
</name>
<xref ref-type="aff" rid="af4-ijms-18-02312">4</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-18-02312"><label>1</label>Department of Cell Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto 860-8555, Japan; <email>harukiodaka@ruri.waseda.jp</email></aff>
<aff id="af2-ijms-18-02312"><label>2</label>Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8551, Japan</aff>
<aff id="af3-ijms-18-02312"><label>3</label>Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo 169-8050, Japan</aff>
<aff id="af4-ijms-18-02312"><label>4</label>Department of Biomedical Chemistry, School of Science and Technology, Kwansei Gakuin University, Sanda City, Hyogo 662-8501, Japan; <email>adachi@kwansei.ac.jp</email></aff>
<author-notes>
<corresp id="c1-ijms-18-02312"><label>*</label>Correspondence: <email>numakawa.yyrmk@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2017</year>
</pub-date>
<volume>18</volume>
<issue>11</issue>
<elocation-id>2312</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 by the authors.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Altered neurogenesis is suggested to be involved in the onset of brain diseases, including mental disorders and neurodegenerative diseases. Neurotrophic factors are well known for their positive effects on the proliferation/differentiation of both embryonic and adult neural stem/progenitor cells (NSCs/NPCs). Especially, brain-derived neurotrophic factor (BDNF) has been extensively investigated because of its roles in the differentiation/maturation of NSCs/NPCs. On the other hand, recent evidence indicates a negative impact of the stress hormone glucocorticoids (GCs) on the cell fate of NSCs/NPCs, which is also related to the pathophysiology of brain diseases, such as depression and autism spectrum disorder. Furthermore, studies including ours have demonstrated functional interactions between neurotrophic factors and GCs in neural events, including neurogenesis. In this review, we show and discuss relationships among the behaviors of NSCs/NPCs, BDNF, and GCs.</p>
</abstract>
<kwd-group>
<kwd>BDNF</kwd>
<kwd>neurogenesis</kwd>
<kwd>neural stem cells</kwd>
<kwd>glucocorticoids</kwd>
<kwd>intracellular signaling</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-18-02312">
<title>1. Introduction</title>
<p>Brain-derived neurotrophic factor (BDNF) is highly expressed in the brain, including hippocampal and cortical regions, and has pivotal roles in the maintenance of neurons in the central nervous system (CNS). Functions of BDNF through TrkB, a high affinity receptor for BDNF, and its downstream intracellular signaling pathways have been intensively studied because the BDNF/TrkB system is essential for neuronal survival and synaptic plasticity in the CNS. It is well established that activation of ERK-, Akt-, and PLCgamma-pathways are triggered by TrkB phosphorylation induced by binding of BDNF, and each pathway contributes a variety of neuronal functions, including the regulation of cell fate [<xref ref-type="bibr" rid="B1-ijms-18-02312">1</xref>,<xref ref-type="bibr" rid="B2-ijms-18-02312">2</xref>,<xref ref-type="bibr" rid="B3-ijms-18-02312">3</xref>]. Recently, growing evidence has suggested that BDNF is also involved in neurogenesis, and newborn neurons contribute to the recovery process of depression-like behaviors [<xref ref-type="bibr" rid="B4-ijms-18-02312">4</xref>,<xref ref-type="bibr" rid="B5-ijms-18-02312">5</xref>]. Importantly, animal models of depression have demonstrated that reduced levels in both BDNF expression and hippocampal neurogenesis occurs along with depressive behaviors, suggesting that a changed status of the BDNF/TrkB system and reduced neurogenesis are associated with depressive symptoms.</p>
<p>Glucocorticoids (GCs) influence neuronal development and functions, as well as BDNF. Blood levels of GCs are regulated by hypothalamus-pituitary-adrenal (HPA) axis activity. It is well known that excess and chronic stress causes hyper activation of the HPA axis, which results in abnormally increased levels of GCs [<xref ref-type="bibr" rid="B6-ijms-18-02312">6</xref>,<xref ref-type="bibr" rid="B7-ijms-18-02312">7</xref>], and such an increased GCs has a role in the onset of mental disorders, including post-traumatic stress disorder and major depressive disorders [<xref ref-type="bibr" rid="B8-ijms-18-02312">8</xref>,<xref ref-type="bibr" rid="B9-ijms-18-02312">9</xref>,<xref ref-type="bibr" rid="B10-ijms-18-02312">10</xref>,<xref ref-type="bibr" rid="B11-ijms-18-02312">11</xref>]. Furthermore, altered neurogenesis under GC stress, especially in hippocampal region, has been an important therapeutic target to develop new drugs because suppression of hippocampal neurogenesis may contribute to the dysregulation of HPA-axis function [<xref ref-type="bibr" rid="B12-ijms-18-02312">12</xref>,<xref ref-type="bibr" rid="B13-ijms-18-02312">13</xref>] and is considered as one of the causes that leads to the onset of the mental disorders mentioned above.</p>
<p>In this review, we focus on crosstalk among BDNF, GCs, and neurogenesis. We discuss recent studies concerning functional interaction between BDNF and GCs in altered neurogenesis, and show an interesting effect of GCs: Alteration in intracellular transport of BDNF protein under GC stress.</p>
</sec>
<sec id="sec2-ijms-18-02312">
<title>2. Role of BDNF in Neurogenesis</title>
<p>BDNF, as one of the neurotrophins, has been intensively studied for its role in survival promotion and the regulation of synaptic plasticity in the CNS [<xref ref-type="bibr" rid="B3-ijms-18-02312">3</xref>,<xref ref-type="bibr" rid="B14-ijms-18-02312">14</xref>]. Importantly, positive roles of BDNF in the neurogenesis have also been demonstrated. It is considered that neurogenesis from neural stem/progenitor cells is restricted to the subventricular zone (SVZ) of the lateral ventricles and subgranular zone (SGZ) in the hippocampal dentate gyrus. In the macaque monkey brain, BDNF expression in the hippocampus and cortex (including prefrontal, temporal, and parietal association cortices) is higher than other brain regions [<xref ref-type="bibr" rid="B15-ijms-18-02312">15</xref>]. Notably, these hippocampal and cortical BDNF expression reaches its highest level during neuronal development, especially at embryonic day 140 and the postnatal second month [<xref ref-type="bibr" rid="B15-ijms-18-02312">15</xref>], implying the stage-specific requirement of BDNF for neuronal development and functions, including neurogenesis.</p>
<p>Increased neurogenesis in the granule cell layer after BDNF infusion into the hippocampus of adult rats (by implanted osmotic pumps for a month) was reported [<xref ref-type="bibr" rid="B16-ijms-18-02312">16</xref>]. SVZ produces neuroblasts that differentiate into interneurons after migrating to the olfactory bulb (OB) in adult rodents. Interestingly, a BDNF mutant mice with a truncation of long 3’UTR of <italic>Bdnf</italic> mRNA, which lack dendritic expression and secretion of BDNF in hippocampal neurons [<xref ref-type="bibr" rid="B17-ijms-18-02312">17</xref>], exhibited a decreased expression of glutamic acid decarboxylase 65, a GABA synthase, and an impaired differentiation of newborn neurons in the SGZ [<xref ref-type="bibr" rid="B18-ijms-18-02312">18</xref>]. Moreover, the selective loss of TrkB in parvalbumin-positive GABAergic interneurons resulted in similar deficits in neurogenesis with reduced neural differentiation [<xref ref-type="bibr" rid="B18-ijms-18-02312">18</xref>]. These results support the positive contributions of BDNF to adult neurogenesis. On the other hand, Galvao and colleagues reported that cell survival and neuronal differentiation into calbindin-positive interneurons were not influenced by loss of TrkB. They found that the grafted progenitors obtained from the SVZ of TrkB knock-out mouse could migrate to the OB in the host wild-type mice and differentiate into interneurons, suggesting that the BDNF/TrkB system is not essential for adult neurogenesis in the SVZ [<xref ref-type="bibr" rid="B19-ijms-18-02312">19</xref>]. Because BDNF has a pivotal role in promoting survival of differentiated neurons, time- and region-specific knockdown of BDNF are necessary to reveal direct contributions of BDNF/TrkB system in neurogenesis, not in survival.</p>
</sec>
<sec id="sec3-ijms-18-02312">
<title>3. Regulation of BDNF Expression and Neurogenesis by Chemicals</title>
<p>Studies have shown upregulation of BDNF and increased neurogenesis occur after chemicals or neurotransmission agonist application. In animal models of depressive disorder, change in expression levels of BDNF and the rate of neurogenesis has been extensively studied. In rats that have been exposed to the chronic mild stress (CMS) to induce memory deficits and anhedonia-like behaviors, piromelatine, a melatonin and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>1D</sub> agonist, exerted beneficial effects against memory deficits and anhedonia-like behavior [<xref ref-type="bibr" rid="B20-ijms-18-02312">20</xref>]. Piromelatine administration reversed reduced expression of BDNF and cAMP response element-binding protein (CREB) in the hippocampus of the CMS rats, with significant recovery in the memory deficits [<xref ref-type="bibr" rid="B20-ijms-18-02312">20</xref>]. Growing evidence indicates that selective serotonin reuptake inhibitors (SSRIs that are used in the treatment of depressive disorders) increase the expression of BDNF. Fluvoxamine, one of the SSRIs, shortened immobility time in the forced swimming test and reversed the downregulation of BDNF in the cerebral cortex and hippocampus of mice received chronic dexamethasone (an agonist for glucocorticoid receptor (GR)) infusion [<xref ref-type="bibr" rid="B21-ijms-18-02312">21</xref>]. Chronic fluoxetine treatment also increased neurogenesis, with an upregulation of BDNF in the medial habenula and medial hypothalamus that are also considered as anxiety-associated brain regions [<xref ref-type="bibr" rid="B22-ijms-18-02312">22</xref>]. Suppression of serotonin transporters by the RNAi technique in the dorsal raphe nucleus of mice increased the amount of extracellular serotonin, neurogenesis, and BDNF levels in the hippocampus [<xref ref-type="bibr" rid="B23-ijms-18-02312">23</xref>]. It is very interesting whether the increased BDNF directly stimulate to produce new-born neurons or not because the activation of latent stem/progenitor cells by neuronal activity itself in the adult hippocampus has been reported [<xref ref-type="bibr" rid="B24-ijms-18-02312">24</xref>]. Recently, an Antidepressant-Like Effect of S 47445 (8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8-dihydro-3H-[1,3]oxazino[6,5-g][1,2,3] benzotriazine-4,9-dione), a positive modulator of AMPA-type glutamate receptors, has been reported [<xref ref-type="bibr" rid="B25-ijms-18-02312">25</xref>]. In animals received chronic corticosterone (a rodent glucocorticoid) administration and exhibited anxiety/depression-like behaviors, treatment of S 47445 reversed the depression-like behaviors and showed neurogenic effects including cell proliferation, survival promotion, and maturation of hippocampal newborn neurons. Interestingly, when neurogenesis deficient mice in which GFAP-positive progenitor cells were killed by ganciclovir treatment [<xref ref-type="bibr" rid="B26-ijms-18-02312">26</xref>] was examined, S 47445 increased hippocampal BDNF and improved several anxiety/depression-like behaviors [<xref ref-type="bibr" rid="B25-ijms-18-02312">25</xref>], suggesting a neurogenesis-independent process in the recovery of anxiety/depression-like behaviors. Furthermore, it has been demonstrated that Norbin, an endogenous regulator of metabotropic glutamate receptor 5 (mGluR5), promoted hippocampal neurogenesis [<xref ref-type="bibr" rid="B27-ijms-18-02312">27</xref>]. Depressive behaviors, such as increased immobility in the forced swim test, and a significant impairment in the proliferation of NSCs/NPCs and the maturation of newborn neurons were demonstrated in Norbin-deficient mice [<xref ref-type="bibr" rid="B27-ijms-18-02312">27</xref>]. With regard to cognitive deficits, an ameliorating effect of taurine on neurodegeneration associated with diabetes mellitus was also studied, and it could be beneficial to protect neurons and improve the learning and memory functions in a diabetic rat model [<xref ref-type="bibr" rid="B28-ijms-18-02312">28</xref>]. Taurine is one of the abundant amino acids in the brain and contributes to the CNS function. In a depression rat model induced by chronic unpredictable mild stress, increased serum levels of corticosterone, deficits in spatial memory, and anxiety were prevented by treatment with taurine before stress exposure. Furthermore, the downregulation of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), and BDNF observed in the animal model were reversed by taurine. This report indicates regulatory functions of taurine both in the HPA-axis and in neurogenesis [<xref ref-type="bibr" rid="B29-ijms-18-02312">29</xref>]. Indeed, it has been demonstrated that taurine improved reduced hippocampal neurogenesis during brain aging [<xref ref-type="bibr" rid="B30-ijms-18-02312">30</xref>].</p>
<p>It has been reported that zinc supplementation increased the serum BDNF levels and improved depressive symptoms in obese or overweight subjects [<xref ref-type="bibr" rid="B31-ijms-18-02312">31</xref>]. In a high-fat diet (HFD)-fed obese mouse model, a low dose of Zn<sup>2+</sup> (15 ppm) reversed HFD-dependent reduction in cell proliferation, neuronal differentiation, and BDNF levels in the hippocampus, whereas a high-dose (60 ppm) enhanced the HFD-reduced hippocampal neurogenesis and BDNF levels [<xref ref-type="bibr" rid="B32-ijms-18-02312">32</xref>]. Zinc is one of the abundant transition metals in the injured brain and was also reported to influence TrkB activation [<xref ref-type="bibr" rid="B33-ijms-18-02312">33</xref>]. Zinc is also involved in the modulation of the spatial learning and memory function, although mice fed Zn<sup>2+</sup> at high-dose (60 ppm) exhibited significant deficits in the memory and decreased levels of glutamate receptors, BDNF, and BDNF/TrkB signaling in the hippocampal region [<xref ref-type="bibr" rid="B34-ijms-18-02312">34</xref>]. It would be interesting, therefore, to investigate whether the changed Zn<sup>2+</sup> levels in injured brain affects neurogenesis via modulating the BDNF/TrkB-signaling.</p>
</sec>
<sec id="sec4-ijms-18-02312">
<title>4. Glucocorticoids and Neurogenesis</title>
<p>Psychosocial stress and the resultant GC response have negative impacts on the hippocampal neurogenesis and the cell fate of NSCs [<xref ref-type="bibr" rid="B35-ijms-18-02312">35</xref>]. It is also well known that high levels of GCs caused by the activated HPA-axis in response to stressful stimuli are associated with mental disorders, including major depression [<xref ref-type="bibr" rid="B36-ijms-18-02312">36</xref>,<xref ref-type="bibr" rid="B37-ijms-18-02312">37</xref>,<xref ref-type="bibr" rid="B38-ijms-18-02312">38</xref>]. Many efforts have been devoted to reveal the mechanisms by which GCs hamper neurogenesis, targeting one of the receptors of GCs, glucocorticoid receptor GR.</p>
<p>GR knockout mice die within a few hours after their birth because of respiratory failure due to lung immaturity. Therefore, GR heterozygous mice (GR+/−) had been use to investigate GCs and GR functions [<xref ref-type="bibr" rid="B39-ijms-18-02312">39</xref>,<xref ref-type="bibr" rid="B40-ijms-18-02312">40</xref>,<xref ref-type="bibr" rid="B41-ijms-18-02312">41</xref>]. GR+/− mice (approximately 50% reduction in GR protein) develop normally without severe systemic symptoms [<xref ref-type="bibr" rid="B40-ijms-18-02312">40</xref>]. Under basal (unstressed) condition, no difference between WT and GR+/− mice regarding depression/anxiety-like behaviors, blood levels of corticosterone, and adult hippocampal neurogenesis was observed. In contrast, under stress conditions, GR+/− mice showed dysregulation of the HPA axis activity and enhanced elevation of corticosterone levels that were induced by stress [<xref ref-type="bibr" rid="B40-ijms-18-02312">40</xref>]. Behavioral tests revealed an increased learned helplessness in the GR+/− mice after receiving unpredictable and uncontrollable foot shocks [<xref ref-type="bibr" rid="B40-ijms-18-02312">40</xref>]. Decreased hippocampal neurogenesis induced by stress was also exacerbated in the GR+/− mice [<xref ref-type="bibr" rid="B41-ijms-18-02312">41</xref>]. The GR+/− mice is indeed a useful animal model of depression because their residual GR expression levels are considered to mimic the levels in severely depressed patients and their hyper-sensitivity to stressful stimuli. However, the reciprocal interaction between the expression levels of GR and the activity of the HPA axis makes it difficult to conclude whether the reduced GR expression itself and/or the elevated GCs induced by disturbance of the HPA axis alter their behaviors and neurogenesis.</p>
<p>To avoid the lethality at birth by systemic GR deletion, a mouse line with brain-specific deletion of GR (GRnestin-cre −/− mice) has been developed [<xref ref-type="bibr" rid="B42-ijms-18-02312">42</xref>]. Importantly, this brain-specific GR deletion did not exhibit any obvious structural abnormality in the brain but did display hypercorticoidism- and Cushing syndrome-like symptoms, such as altered fat distribution and a reduced bone density. Interestingly, reduced anxiety under basal conditions was observed in the GRnestin-cre −/− mice. Remarkably, in spite of the elevated basal levels of plasma corticosterone, normal hippocampal neurogenesis in the GRnestin-cre −/− mice was revealed [<xref ref-type="bibr" rid="B43-ijms-18-02312">43</xref>]. When considering the phenotypes of the GR +/− mice, targeting to reduce GR levels in the brain may not be a good therapeutic strategy because residual GR expression in GR +/− mice is sufficient to suppress neurogenesis after stress exposure, and the reduction in the GR levels can impair HPA axis functions.</p>
<p>We recently reported that corticosterone exposure during differentiation and maturation reduced the expression of neuron- and astrocyte-specific proteins in cultured embryonic NSCs/NPCs [<xref ref-type="bibr" rid="B44-ijms-18-02312">44</xref>]. Corticosterone also decreased cell survival of NSCs/NPCs after differentiation, although it did not affect the proliferation of NSCs/NPCs [<xref ref-type="bibr" rid="B44-ijms-18-02312">44</xref>]. Interestingly, knockdown of GR selectively in newborn cells in the hippocampus caused ectopic positioning of the new granule cells, and increased the synaptic contacts and basal neuronal excitability parallel with an impairment in the fear memory consolidation [<xref ref-type="bibr" rid="B45-ijms-18-02312">45</xref>]. As expected, there is a lot of evidence concerning the negative effect of GC exposure on the neurogenesis. Anacker reported that mRNA expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) was increased in the peripheral blood of patients with depression and in the hippocampus of rats exposed to unpredictable chronic mild stress [<xref ref-type="bibr" rid="B46-ijms-18-02312">46</xref>]. They also confirmed that an inhibitor for SGK1 counteracted the reduced neurogenesis caused by GC exposure by using the hippocampal progenitor cell line. Recently, it has been reported that baicalin, a flavonoid extracted from Radix Scutellariae, improved anxiety/depression-like behavior in mouse after chronic corticosterone treatment. Oral administration of baicalin reversed the corticosterone-induced reduction in hippocampal neurogenesis and phosphorylation of SGK [<xref ref-type="bibr" rid="B47-ijms-18-02312">47</xref>], implying a close relationship among GCs action via SGK-signaling, hippocampal neurogenesis, and depressive behaviors. Importantly, the expression of depressive behaviors and the reduction of hippocampal neurogenesis in rats appears to depend on the duration of GC treatment. Lussier compared the impacts of daily corticosterone injection for 7, 14, or 21 days, and revealed that a gradual increase in depression-like behaviors with a gradual decrease in the number of immature granule cells in the hippocampus [<xref ref-type="bibr" rid="B48-ijms-18-02312">48</xref>]. Kott compared different methods to administer corticosterone to adult female rats, including subcutaneous injection, through the drinking water and via the implantation of pellets. The subcutaneous injection elevated serum corticosterone levels continuously while the pellet implantation induced a transient increase and no increase was observed in rats administered corticosterone via drinking water [<xref ref-type="bibr" rid="B49-ijms-18-02312">49</xref>]. Furthermore, the only animal group injected corticosterone exhibited longer immobility time in the forced swimming test [<xref ref-type="bibr" rid="B49-ijms-18-02312">49</xref>].</p>
<p>As mentioned above, GCs exert negative influences on hippocampal neurogenesis through GR activation. On the other hand, mineralocorticoid receptor (MR) to which GCs also bind functions as a positive regulator for neurogenesis. Fludrocortisone, a potent MR agonist, increased the survival and proliferation of rat hippocampal progenitor cells, and these positive effects were attenuated by high dose of dexamethasone [<xref ref-type="bibr" rid="B50-ijms-18-02312">50</xref>], implying that MR has an effect opposite to GR in neurogenesis. Indeed, MR improves deficits in both memory formation and hippocampal neurogenesis caused by chronic early life stress (ELS) [<xref ref-type="bibr" rid="B51-ijms-18-02312">51</xref>]. Using a transgenic mouse line with forebrain-specific MR overexpression, Kanatsou showed that limited nesting and bedding materials hampered memory formation in wildtype but not in the MR overexpression mice. They also reported an increased number of cells expressing a marker for immature neurons in the dentate gyrus of the MR overexpression mice after the ELS, as compared with wild-type mice [<xref ref-type="bibr" rid="B51-ijms-18-02312">51</xref>]. Because corticosterone binds both GR and MR with low and high affinity, respectively, changed MR levels affects GR activation by corticosterone. It is considered that GR acts as a negative mediator but MR does as a positive one in the depression-like behaviors [<xref ref-type="bibr" rid="B52-ijms-18-02312">52</xref>]. Therefore, to estimate the expression levels of GR and MR in normal and stressful conditions is important. The crosstalk between GR- and MR-dependent intracellular signaling would be an important issue in future studies.</p>
</sec>
<sec id="sec5-ijms-18-02312">
<title>5. Crosstalk of BDNF and Glucocorticoids in Neurogenesis</title>
<p>Because both BDNF/TrkB and GCs/GR systems are involved in neurogenesis, the relationship between these systems in neurogenesis is of interest. Therefore, the interaction in the neural function, including neurotransmitter release, synaptic structure has been investigated [<xref ref-type="bibr" rid="B14-ijms-18-02312">14</xref>,<xref ref-type="bibr" rid="B53-ijms-18-02312">53</xref>]. Many studies showed a negative influence of systemic administration of GCs on BDNF mRNA expression in hippocampal and cortical regions [<xref ref-type="bibr" rid="B54-ijms-18-02312">54</xref>,<xref ref-type="bibr" rid="B55-ijms-18-02312">55</xref>,<xref ref-type="bibr" rid="B56-ijms-18-02312">56</xref>]. It has also been suggested that translation, procession, and secretion of BDNF are regulated by the GC system [<xref ref-type="bibr" rid="B57-ijms-18-02312">57</xref>]. Hodes reported a difference in protein expression of BDNF in response to GCs between C57BL/6J and MRL/MpJ strains [<xref ref-type="bibr" rid="B58-ijms-18-02312">58</xref>]. Chronic administration of corticosterone reduced expression of BDNF in C57BL/6J strain, but not in the MRL/MpJ strain [<xref ref-type="bibr" rid="B58-ijms-18-02312">58</xref>], which is known to have a large regenerative capacity against the tissue injury [<xref ref-type="bibr" rid="B59-ijms-18-02312">59</xref>]. Interestingly, the MRL/MpJ mouse strain also displayed an enhanced elevation in cell proliferation in the hippocampus and BDNF protein levels after antidepressants treatment, comparing to those of C57BL/6J mice [<xref ref-type="bibr" rid="B60-ijms-18-02312">60</xref>]. More intimate interactions between the BDNF/TrkB and GCs/GR systems have been demonstrated. It has been demonstrated that mRNA expression of BDNF was suppressed by GC exposure via binding of GR to the regulatory sequences of the <italic>Bdnf</italic> gene in neuron-like cells established from mouse hippocampal cell [<xref ref-type="bibr" rid="B61-ijms-18-02312">61</xref>]. There are several reports about the direct interaction between kinase receptors and GR to influence intracellular signaling [<xref ref-type="bibr" rid="B62-ijms-18-02312">62</xref>,<xref ref-type="bibr" rid="B63-ijms-18-02312">63</xref>]. We previously reported that TrkB also interacted with GR and regulated Ca<sup>2+</sup> signaling mediated by PLCgamma [<xref ref-type="bibr" rid="B64-ijms-18-02312">64</xref>]. Furthermore, phosphorylation of GR (at Ser155, Ser287, and Ser246) is induced by BDNF application for 30 min in cortical neurons [<xref ref-type="bibr" rid="B65-ijms-18-02312">65</xref>]. Such phosphorylations of GR may be involved in neurogenesis associated with antidepressant treatment. Flavonoid baicalin administration improved the chronic corticosterone-induced depressive behaviors of mouse [<xref ref-type="bibr" rid="B47-ijms-18-02312">47</xref>]. Baicalin treatment reversed the GR downregulation and increased phosphorylation of GR (at Ser203 and Ser211) with a significant improvement in the suppressed hippocampal neurogenesis. Interestingly, the increased expression of FK506 binding protein 51 (FKBP5) and phosphorylation of SGK1, which was caused by corticosterone were also ameliorated by Baicalin [<xref ref-type="bibr" rid="B47-ijms-18-02312">47</xref>]. The GCs/GR system appears to affect the intracellular signaling pathways involved in the BDNF/TrkB system. Treatment with ginsenoside Rg1, one of steroidal saponins, promoted the differentiation of mouse embryonic stem (ES) cells toward neuron-like cells, which was inhibited by a GR antagonist RU486. Furthermore, Rg1 activated ERK- and Akt-signaling pathways, and the neuronal differentiation triggered by Rg1 was repressed by inhibitors for ERK- or Akt signaling [<xref ref-type="bibr" rid="B66-ijms-18-02312">66</xref>]. Chen et al. reported that an injection of RU486 into the hippocampus disturbed the inhibitory avoidance memory formation in rats. The RU486 injection also induced significantly decreased levels of CaMKIIalpha and Akt phosphorylation in addition to a trend toward downregulation of phospho-CREB and phospho-TrkB while BDNF rescued the levels of phospho-CREB and phospho-TrkB with a rescuing trend in Phospho-Akt [<xref ref-type="bibr" rid="B67-ijms-18-02312">67</xref>].</p>
</sec>
<sec id="sec6-ijms-18-02312">
<title>6. The Effect of Glucocorticoids on BDNF Transport</title>
<p>One of the remarkable features of neural cells is their polarized morphology. Secreted proteins in neurons, therefore, need to travel long distances in axons and/or dendrites. There are two main pathways by which neurons secrete proteins synthesized in the cell body; constitutive and regulated pathways. BDNF is preferentially secreted via the regulated pathway in which proteins are sorted into secretory vesicles, transported distally (anterograde), and proximally (retrograde) to the secretion sites, and released in response to depolarization-induced intracellular Ca<sup>2+</sup> elevation, whereas NGF and NT-3 are constitutively and spontaneously secreted from neurons [<xref ref-type="bibr" rid="B68-ijms-18-02312">68</xref>,<xref ref-type="bibr" rid="B69-ijms-18-02312">69</xref>,<xref ref-type="bibr" rid="B70-ijms-18-02312">70</xref>,<xref ref-type="bibr" rid="B71-ijms-18-02312">71</xref>]. The BDNF protein is synthesized as the precursor form (pro-BDNF, 32 kDa) in the rough endoplasmic reticulum (ER) and dendrites, and many of them are secreted as the mature form (13 kDa) after receiving proteolytic cleavage in the secretory vesicles. Kinesin and dynein motor protein complexes shoulder the intracellular transport of BDNF-containing vesicles, tracking on microtubules distributed throughout polarized neurons [<xref ref-type="bibr" rid="B72-ijms-18-02312">72</xref>,<xref ref-type="bibr" rid="B73-ijms-18-02312">73</xref>]. Huntingtin (htt) protein also has an important role in the BDNF-containing vesicle transport. Although mutations in the htt gene results in the production of htt proteins with polyglutamine expansion (polyQ), which is causal for Huntington’s disease (HD) [<xref ref-type="bibr" rid="B74-ijms-18-02312">74</xref>], several studies unveiled a beneficial aspect of wild-type htt protein as a positive regulator for the vesicle transport. It was showed by Saudou and colleagues that wild-type htt is involved in the motor complex, in which htt-associated protein-1 (HAP1)/kinesin and HAP1/p150<sup>Glued</sup>/dynactin/dynein engage in the anterograde and retrograde transport, respectively [<xref ref-type="bibr" rid="B75-ijms-18-02312">75</xref>,<xref ref-type="bibr" rid="B76-ijms-18-02312">76</xref>] (<xref ref-type="fig" rid="ijms-18-02312-f001">Figure 1</xref>). Overexpression of wild-type htt increased the velocity of vesicle transport of BDNF, and decreased the proportion of static vesicles in cultured cortical neurons, while knockdown of wild-type htt caused the opposite effects [<xref ref-type="bibr" rid="B77-ijms-18-02312">77</xref>]. Their study clearly proved that a shortage of BDNF supply from cortical to striatal neurons caused by the diminished transport of BDNF as well as the aggregation of mutant htt is a cause of striatal neuronal loss, a common pathological feature of Huntington’s disease. These results strongly suggest an important role of normal intracellular transport of BDNF in brain function and encouraged to study a possible link between BDNF vesicle transport and GCs. We recently reported that DEX, a synthetic glucocorticoid with a high affinity for GR, promoted BDNF vesicle transport in cortical neurons through the up-regulation of htt expression [<xref ref-type="bibr" rid="B78-ijms-18-02312">78</xref>] (<xref ref-type="fig" rid="ijms-18-02312-f002">Figure 2</xref>). In general, activated GR directly binds to the glucocorticoid response element (GRE) in the regulatory regions of many genes and promote or suppress their transcription [<xref ref-type="bibr" rid="B79-ijms-18-02312">79</xref>]. Although DEX increased htt protein levels and accelerated vesicular transport through GR activation, the GRE sequence has not been identified in the regulatory region of the htt gene so far. Therefore, GR would increase intracellular htt protein levels via other signaling molecules by stabilizing htt proteins and/or mRNA or regulating its transcription and/or translation. Furthermore, Brigadski et al. revealed a change in the vesicular transport of BDNF in hippocampal neurons of an Alzheimer’s disease (AD) mouse model (5xFAD), in which amyloid β,β is abnormally increased and develops severe amyloid pathology [<xref ref-type="bibr" rid="B80-ijms-18-02312">80</xref>]. Transport of BDNF vesicles to both directions was decreased in cultured hippocampal neurons of 5xFAD mice and in that of 5xFAD wild-type littermates treated with extracellular Aβ, suggesting a negative effect of extracellular Aβ on intracellular transport of BDNF. Impaired memory functions of the mouse model, therefore, could attribute to an early deficit in BDNF supplementation. Interestingly, Dai and colleagues also reported that cortisol (GC in human) affected the axonal transport in cortical neurons that were obtained from post-mortem human brains [<xref ref-type="bibr" rid="B81-ijms-18-02312">81</xref>]. They found a bell-shaped dose-response for cortisol in the transport distance in both healthy humans and AD patients, although higher doses of cortisol were required for neurons of AD patients to achieve similar effects observed in that of healthy humans. When considering that synaptic plasticity and memory functions are impaired in the brains of AD patients [<xref ref-type="bibr" rid="B82-ijms-18-02312">82</xref>], and that GCs enhance memory consolidation in which BDNF has essential roles as a synaptic modulator [<xref ref-type="bibr" rid="B83-ijms-18-02312">83</xref>,<xref ref-type="bibr" rid="B84-ijms-18-02312">84</xref>], these results, including ours, suggest that an “appropriate dose” of GCs may play a beneficial role for patients with HD and AD by promoting neuronal survival and memory consolidation through the enhanced neuronal transport of BDNF. Furthermore, future studies on whether the altered transport of BDNF in mature neurons under GC stress impacts on the fate of newborn neurons generated via neurogenesis are important.</p>
</sec>
<sec id="sec7-ijms-18-02312">
<title>7. Crosstalk of BDNF and Glucocorticoids in Neurodegeneration</title>
<p>It has been suggested that the process of neurodegeneration, as well as neurogenesis, is influenced by GCs stress [<xref ref-type="bibr" rid="B85-ijms-18-02312">85</xref>]. Therefore, we briefly mention some of the current reports regarding an impact of BDNF and GCs on the neurodegenerative pathologies in this section. Rothman et al. reported that a triple-transgenic mouse model of AD (3xTgAD mice expressing mutant presenilin-1<sub>M146V</sub>, and amyloid precursor protein<sub>Swe</sub>, and Tau<sub>P301L</sub>) exhibited an elevated levels of hippocampal Aβ oligomers, increased plasma GCs, and decreased BDNF levels after chronic mild social stress, whereas such an elevated Aβ and decreased BDNF were not observed in control mice under the stress, indicating that the AD model animal is more vulnerable to the chronic stress [<xref ref-type="bibr" rid="B86-ijms-18-02312">86</xref>]. Growing evidence suggests that a loss of neurotrophic support of BDNF may exacerbate the neuropathology in AD. It is well-known that noradrenergic neurons located in the locus coeruleus (LC) brainstem area is severely damaged in AD. Braun et al. has shown that a depletion of BDNF from a target region of the LC innervation resulted in a retrograde damage of noradrenergic neurons in an AD model mice expressing familial mutations for human presenilin-1 and amyloid precursor protein [<xref ref-type="bibr" rid="B87-ijms-18-02312">87</xref>]. Furthermore, increased levels of mature BDNF by administrating an inhibitor for plasminogen-activator inhibitor-1 (PAI-1, an inhibitor of plasmin-dependent conversion of pro-BDNF to mature BDNF) improved cognitive function and hippocampal amyloid burden in AD model mice that were overexpressing human amyloid precursor protein [<xref ref-type="bibr" rid="B88-ijms-18-02312">88</xref>]. In general, BDNF-dependent neurotrophic effects including survival promotion require TrkB activation via binding of mature BDNF, not pro-BDNF, the precursor form that preferentially binds to p75 receptor [<xref ref-type="bibr" rid="B89-ijms-18-02312">89</xref>]. Interestingly, a recent study reported that exogenous application of pro-BDNF repressed the proliferation, differentiation, and migration of cultured mouse neural stem cells [<xref ref-type="bibr" rid="B90-ijms-18-02312">90</xref>]. These studies suggest that mature BDNF has an essential role to prevent neuronal degeneration caused by Aβ toxicity. When considering that chronic GCs stress impairs the BDNF/TrkB system, excess GCs may be a risk factor for the development/progression of neurodegenerative pathologies of AD. As expected, it has also been demonstrated that depression could be a risk factor for the onset of AD [<xref ref-type="bibr" rid="B91-ijms-18-02312">91</xref>]. Furthermore, dysregulation of the HPA axis and increased GCs in patients with Parkinson’s disease (PD) have been reported and GCs stress may contribute to the progression of the neurodegenerative process in PD [<xref ref-type="bibr" rid="B85-ijms-18-02312">85</xref>,<xref ref-type="bibr" rid="B92-ijms-18-02312">92</xref>]. Therefore, the decreased expression/function of BDNF in which chronic GC stress via GR activation is involved may contribute to both impaired neurogenesis and the neurodegenerative process.</p>
<p>Recently, natural compounds including flavonoids and small chemicals that stimulate BDNF/TrkB system have been considered as one of the candidates for therapeutic intervention [<xref ref-type="bibr" rid="B93-ijms-18-02312">93</xref>]. Interestingly, it has been shown that increased levels of BDNF mRNA in the temporal cortex of patients with pharmacoresistant epilepsy, and the expression of GR was also influenced in the same direction [<xref ref-type="bibr" rid="B94-ijms-18-02312">94</xref>], implying a converging behavior of BDNF and GR levels in the CNS of some neurological disorders. When considering such converging behavior, possible strategies to improve the abnormally activated GR functions should be studied carefully, although small compounds and chemicals may be beneficial tool to treat mental disorders and neurodegeneration via ameliorating the BDNF/TrkB system.</p>
</sec>
<sec id="sec8-ijms-18-02312">
<title>8. Conclusions</title>
<p>In this review, we introduced the functional interaction between the BDNF/TrkB and the GCs/GR systems in the neurogenesis. High levels of GCs seem to exert a negative influence on neurogenesis via the low affinity receptor GR-mediated function (see <xref ref-type="table" rid="ijms-18-02312-t001">Table 1</xref> and <xref ref-type="fig" rid="ijms-18-02312-f003">Figure 3</xref>). Recent evidence has demonstrated that activity of GR is modulated by BDNF/TrkB-related intracellular signaling, in turn, the intensive GC stress downregulates BDNF expression, although there is little information regarding whether the decreased BDNF by GC stress is indeed a direct cause for suppression of neurogenesis, or whether it is just a phenotype that is concurrently occurred. Increased GCs also exert a negative influence on neurodegenerative pathologies. Therefore, further examinations concerning the functional crosstalk between the two systems are essential to decrease the risk of neurodegenerative disease and mental disorders.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This study was supported by grants from the Grant-in-Aid for Scientific Research(C) (JSPS KAKENHI JP16K06996) (T.N.) in the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and supported by grants from by Takeda Science Foundation (T.N. and N.A).</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>Tadahiro Numakawa wrote and edited the paper; Haruki Odaka wrote the paper; Naoki Adachi wrote the paper.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-18-02312">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>M.V.</given-names>
</name>
</person-group>
<article-title>Neurotrophins and their receptors: A convergence point for many signalling pathways</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2003</year>
<volume>4</volume>
<fpage>299</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1078</pub-id>
<pub-id pub-id-type="pmid">12671646</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-18-02312">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nagappan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nathan</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Wren</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2013</year>
<volume>14</volume>
<fpage>401</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3505</pub-id>
<pub-id pub-id-type="pmid">23674053</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-18-02312">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohira</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A new aspect of the TrkB signaling pathway in neural plasticity</article-title>
<source/>Curr. Neuropharmacol.
          <year>2009</year>
<volume>7</volume>
<fpage>276</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.2174/157015909790031210</pub-id>
<pub-id pub-id-type="pmid">20514207</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-18-02312">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Saikosaponin D relieves unpredictable chronic mild stress induced depressive-like behavior in rats: Involvement of HPA axis and hippocampal neurogenesis</article-title>
<source/>Psychopharmacology
          <year>2017</year>
<volume>234</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-017-4720-8</pub-id>
<pub-id pub-id-type="pmid">27761587</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-18-02312">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Antidepressant-like effects of tetrahydroxystilbene glucoside in mice: Involvement of BDNF signaling cascade in the hippocampus</article-title>
<source/>CNS. Neurosci. Ther.
          <year>2017</year>
<volume>23</volume>
<fpage>627</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1111/cns.12708</pub-id>
<pub-id pub-id-type="pmid">28547794</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-18-02312">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ising</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Künzel</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Nickel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Modell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The combined dexamethasone/CRH test as a potential surrogate marker in depression</article-title>
<source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
          <year>2005</year>
<volume>29</volume>
<fpage>1085</fpage>
<lpage>1093</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2005.03.014</pub-id>
<pub-id pub-id-type="pmid">15950349</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-18-02312">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Otsubo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Oshima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nakagome</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kamijima</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression</article-title>
<source/>Psychoneuroendocrinology
          <year>2008</year>
<volume>33</volume>
<fpage>152</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2007.10.011</pub-id>
<pub-id pub-id-type="pmid">18068306</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-18-02312">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Cortisol and depression: Three questions for psychiatry</article-title>
<source/>Psychol. Med.
          <year>2013</year>
<volume>43</volume>
<fpage>449</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291712000955</pub-id>
<pub-id pub-id-type="pmid">22564216</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-18-02312">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The corticosteroid receptor hypothesis of depression</article-title>
<source/>Neuropsychopharmacology
          <year>2000</year>
<volume>23</volume>
<fpage>477</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1016/S0893-133X(00)00159-7</pub-id>
<pub-id pub-id-type="pmid">11027914</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-18-02312">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Griffin</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Charron</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Al-Daccak</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Post-traumatic stress disorder: Revisiting adrenergics, glucocorticoids, immune system effects and homeostasis</article-title>
<source/>Clin. Transl. Immunology.
          <year>2014</year>
<volume>3</volume>
<fpage>e27</fpage>
<pub-id pub-id-type="doi">10.1038/cti.2014.26</pub-id>
<pub-id pub-id-type="pmid">25505957</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-18-02312">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raglan</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Schulkin</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The role of glucocorticoids and corticotropin-releasing hormone regulation on anxiety symptoms and response to treatment</article-title>
<source/>Endocr. Connect.
          <year>2017</year>
<volume>6</volume>
<fpage>R1</fpage>
<lpage>R7</lpage>
<pub-id pub-id-type="doi">10.1530/EC-16-0100</pub-id>
<pub-id pub-id-type="pmid">28119322</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-18-02312">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roozendaal</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Power</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Brooke</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Sapolsky</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>McGaugh</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression</article-title>
<source/>Nat. Neurosci.
          <year>2001</year>
<volume>4</volume>
<fpage>1169</fpage>
<lpage>1171</lpage>
<pub-id pub-id-type="doi">10.1038/nn766</pub-id>
<pub-id pub-id-type="pmid">11713467</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-18-02312">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furay</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Bruestle</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>The role of the forebrain glucocorticoid receptor in acute and chronic stress</article-title>
<source/>Endocrinology
          <year>2008</year>
<volume>149</volume>
<fpage>5482</fpage>
<lpage>5490</lpage>
<pub-id pub-id-type="doi">10.1210/en.2008-0642</pub-id>
<pub-id pub-id-type="pmid">18617609</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-18-02312">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and glucocorticoids: Reciprocal influence on the central nervous system</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>239</volume>
<fpage>157</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.09.073</pub-id>
<pub-id pub-id-type="pmid">23069755</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-18-02312">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Differential expression patterns of TrkB ligands in the macaque monkey brain</article-title>
<source/>Neuroreport
          <year>2004</year>
<volume>15</volume>
<fpage>2507</fpage>
<lpage>2511</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-200411150-00015</pub-id>
<pub-id pub-id-type="pmid">15538184</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-18-02312">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scharfman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Macleod</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Phani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Antonelli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Croll</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats</article-title>
<source/>Exp. Neurol.
          <year>2005</year>
<volume>192</volume>
<fpage>348</fpage>
<lpage>356</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2004.11.016</pub-id>
<pub-id pub-id-type="pmid">15755552</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-18-02312">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Gharami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>G.Y.</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Vanevski</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct role of long 3’ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons</article-title>
<source/>Cell
          <year>2008</year>
<volume>134</volume>
<fpage>175</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.05.045</pub-id>
<pub-id pub-id-type="pmid">18614020</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-18-02312">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waterhouse</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Orefice</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Baydyuk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>G.Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>14318</fpage>
<lpage>14330</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0709-12.2012</pub-id>
<pub-id pub-id-type="pmid">23055503</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-18-02312">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galvão</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Garcia-Verdugo</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Alvarez-Buylla</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor signaling does not stimulate subventricular zone neurogenesis in adult mice and rats</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>13368</fpage>
<lpage>13383</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2918-08.2008</pub-id>
<pub-id pub-id-type="pmid">19074010</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-18-02312">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Laudon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats</article-title>
<source/>Psychopharmacology
          <year>2016</year>
<volume>233</volume>
<fpage>2229</fpage>
<lpage>2239</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-016-4272-3</pub-id>
<pub-id pub-id-type="pmid">27007604</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-18-02312">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Izumo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Karube</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Morikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kameyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fluvoxamine moderates reduced voluntary activity following chronic dexamethasone infusion in mice via recovery of BDNF signal cascades</article-title>
<source/>Neurochem. Int.
          <year>2014</year>
<volume>69</volume>
<fpage>9</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2014.02.002</pub-id>
<pub-id pub-id-type="pmid">24582626</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-18-02312">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sachs</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Caron</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Chronic fluoxetine increases extra-hippocampal neurogenesis in adult mice</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <year>2015</year>
<volume>18</volume>
<pub-id pub-id-type="doi">10.1093/ijnp/pyu029</pub-id>
<pub-id pub-id-type="pmid">25583694</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-18-02312">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrés-Coy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pilar-Cuellar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Masana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cortés</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Carmona</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Campa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pazos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Montefeltro</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis</article-title>
<source/>Transl. Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e211</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2012.135</pub-id>
<pub-id pub-id-type="pmid">23321808</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-18-02312">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Sah</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bartlett</surname>
<given-names>P.F.</given-names>
</name>
</person-group>
<article-title>Latent stem and progenitor cells in the hippocampus are activated by neural excitation</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>5240</fpage>
<lpage>5247</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0344-08.2008</pub-id>
<pub-id pub-id-type="pmid">18480280</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-18-02312">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendez-David</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Guilloux</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Papp</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tritschler</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mocaer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gardier</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Bretin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms</article-title>
<source/>Front. Pharmacol.
          <year>2017</year>
<volume>8</volume>
<fpage>462</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2017.00462</pub-id>
<pub-id pub-id-type="pmid">28769796</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-18-02312">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schloesser</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Manji</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Martinowich</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response</article-title>
<source/>Neuroreport.
          <year>2009</year>
<volume>20</volume>
<fpage>553</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="doi">10.1097/WNR.0b013e3283293e59</pub-id>
<pub-id pub-id-type="pmid">19322118</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-18-02312">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Warner-Schmidt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Varela</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Enikolopov</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Flajolet</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Norbin ablation results in defective adult hippocampal neurogenesis and depressive-like behavior in mice</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>9745</fpage>
<lpage>9750</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1510291112</pub-id>
<pub-id pub-id-type="pmid">26195764</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-18-02312">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahmeier</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Zavalhia</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Tortorelli</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Huf</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Géa</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Meurer</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>da Cruz Fernandes</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The effect of taurine and enriched environment on behaviour, memory and hippocampus of diabetic rats</article-title>
<source/>Neurosci. Lett.
          <year>2016</year>
<volume>630</volume>
<fpage>84</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2016.07.032</pub-id>
<pub-id pub-id-type="pmid">27471162</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-18-02312">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>R.Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>4989</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-05051-3</pub-id>
<pub-id pub-id-type="pmid">28694433</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-18-02312">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gebara</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Udry</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sultan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Toni</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Taurine increases hippocampal neurogenesis in aging mice</article-title>
<source/>Stem. Cell. Res.
          <year>2015</year>
<volume>14</volume>
<fpage>369</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="doi">10.1016/j.scr.2015.04.001</pub-id>
<pub-id pub-id-type="pmid">25889858</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-18-02312">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solati</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jazayeri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tehrani-Doost</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mahmoodianfard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gohari</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial</article-title>
<source/>Nutr. Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>162</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1179/1476830513Y.0000000105</pub-id>
<pub-id pub-id-type="pmid">24621065</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-18-02312">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nam</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>I.K.</given-names>
</name>
<name>
<surname>Seong</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>Y.S.</given-names>
</name>
</person-group>
<article-title>Differential Effects of Low- and High-dose Zinc Supplementation on Synaptic Plasticity and Neurogenesis in the Hippocampus of Control and High-fat Diet-fed Mice</article-title>
<source/>Neurochem. Res.
          <fpage>2017</fpage>
<pub-id pub-id-type="doi">10.1007/s11064-017-2353-2</pub-id>
<pub-id pub-id-type="pmid">28770438</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-18-02312">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poddar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rajagopal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shuttleworth</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Zn<sup>2+</sup>-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP: MOLECULAR BASIS FOR ZN<sup>2+</sup>-INDUCED ERK MAPK ACTIVATION</article-title>
<source/>J. Biol. Chem.
          <year>2016</year>
<volume>291</volume>
<fpage>813</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M115.663468</pub-id>
<pub-id pub-id-type="pmid">26574547</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-18-02312">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>X.P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>R.X.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F.X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e55384</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0055384</pub-id>
<pub-id pub-id-type="pmid">23383172</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-18-02312">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzsimons</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Herbert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>O.C.</given-names>
</name>
<name>
<surname>Lucassen</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Lightman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Circadian and ultradian glucocorticoid rhythmicity: Implications for the effects of glucocorticoids on neural stem cells and adult hippocampal neurogenesis</article-title>
<source/>Front. Neuroendocrinol.
          <year>2016</year>
<volume>41</volume>
<fpage>44</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2016.05.001</pub-id>
<pub-id pub-id-type="pmid">27234350</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-18-02312">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>von Bardeleben</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Wiedemann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Stalla</surname>
<given-names>G.K.</given-names>
</name>
</person-group>
<article-title>Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST non-suppression</article-title>
<source/>Biol. Psychiatry
          <year>1987</year>
<volume>22</volume>
<fpage>228</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(87)90237-X</pub-id>
<pub-id pub-id-type="pmid">3028512</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-18-02312">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holsboer-Trachsler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stohler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hatzinger</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Repeated administration of the combined dexa-methasone human corticotropin releasing hormone stimulation test during treatment of depression</article-title>
<source/>Psychiatry Res.
          <year>1991</year>
<volume>38</volume>
<fpage>163</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/0165-1781(91)90041-M</pub-id>
<pub-id pub-id-type="pmid">1661430</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-18-02312">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The influence of glucocorticoids on neuronal survival and synaptic function</article-title>
<source/>Biomol. Concepts
          <year>2012</year>
<volume>3</volume>
<fpage>495</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1515/bmc-2012-0012</pub-id>
<pub-id pub-id-type="pmid">25436554</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-18-02312">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cole</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Blendy</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Monaghan</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Krieglstein</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Aguzzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fantuzzi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hummler</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Unsicker</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schütz</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation</article-title>
<source/>Genes Dev.
          <year>1995</year>
<volume>9</volume>
<fpage>1608</fpage>
<lpage>1621</lpage>
<pub-id pub-id-type="doi">10.1101/gad.9.13.1608</pub-id>
<pub-id pub-id-type="pmid">7628695</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-18-02312">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chourbaji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hellweg</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Urani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zacher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zink</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hörtnagl</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Flor</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Henn</surname>
<given-names>F.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<fpage>6243</fpage>
<lpage>6250</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0736-05.2005</pub-id>
<pub-id pub-id-type="pmid">15987954</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-18-02312">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kronenberg</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kirste</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Inta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chourbaji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Heuser</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Endres</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gass</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Reduced hippocampal neurogenesis in the GR(+/−) genetic mouse model of depression</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2009</year>
<volume>259</volume>
<fpage>499</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-009-0036-y</pub-id>
<pub-id pub-id-type="pmid">19644729</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-18-02312">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tronche</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kellendonk</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kretz</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gass</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Anlag</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Orban</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schütz</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety</article-title>
<source/>Nat. Genet.
          <year>1999</year>
<volume>23</volume>
<fpage>99</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1038/12703</pub-id>
<pub-id pub-id-type="pmid">10471508</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-18-02312">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gass</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kretz</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wolfer</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tronche</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Kellendonk</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lipp</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schütz</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice</article-title>
<source/>EMBO Rep.
          <year>2000</year>
<volume>1</volume>
<fpage>447</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1093/embo-reports/kvd088</pub-id>
<pub-id pub-id-type="pmid">11258486</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-18-02312">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Numakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ooshima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Chronic glucocorticoid exposure suppressed the differentiation and survival of embryonic neural stem/progenitor cells: Possible involvement of ERK and PI3K/Akt signaling in the neuronal differentiation</article-title>
<source/>Neurosci. Res.
          <year>2016</year>
<volume>113</volume>
<fpage>28</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2016.07.002</pub-id>
<pub-id pub-id-type="pmid">27432545</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-18-02312">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzsimons</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>van Hooijdonk</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zalachoras</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brinks</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schouten</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Saaltink</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Dijkmans</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Steindler</surname>
<given-names>D.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior</article-title>
<source/>Mol. Psychiatry
          <year>2013</year>
<volume>8</volume>
<fpage>993</fpage>
<lpage>1005</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.123</pub-id>
<pub-id pub-id-type="pmid">22925833</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-18-02312">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anacker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cattaneo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Musaelyan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zunszain</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Horowitz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Molteni</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luoni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tansey</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gennarelli</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>8708</fpage>
<lpage>8713</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1300886110</pub-id>
<pub-id pub-id-type="pmid">23650397</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-18-02312">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Baicalin promotes hippocampal neurogenesis via SGK1- and FKBP5-mediated glucocorticoid receptor phosphorylation in a neuroendocrine mouse model of anxiety/depression</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>30951</fpage>
<pub-id pub-id-type="doi">10.1038/srep30951</pub-id>
<pub-id pub-id-type="pmid">27502757</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-18-02312">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lussier</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Lebedeva</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fenton</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Guskjolen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caruncho</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Kalynchuk</surname>
<given-names>L.E.</given-names>
</name>
</person-group>
<article-title>The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus</article-title>
<source/>Neuropharmacology
          <year>2013</year>
<volume>71</volume>
<fpage>174</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.012</pub-id>
<pub-id pub-id-type="pmid">23608736</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-18-02312">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kott</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Mooney-Leber</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Shoubah</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Brummelte</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Effectiveness of different corticosterone administration methods to elevate corticosterone serum levels, induce depressive-like behavior, and affect neurogenesis levels in female rats</article-title>
<source/>Neuroscience
          <year>2016</year>
<volume>312</volume>
<fpage>201</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.11.006</pub-id>
<pub-id pub-id-type="pmid">26556064</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-18-02312">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gesmundo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Villanova</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gargantini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Arvat</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ghigo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Granata</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The Mineralocorticoid Agonist Fludrocortisone Promotes Survival and Proliferation of Adult Hippocampal Progenitors</article-title>
<source/>Front. Endocrinol.
          <year>2016</year>
<volume>7</volume>
<fpage>66</fpage>
<pub-id pub-id-type="doi">10.3389/fendo.2016.00066</pub-id>
<pub-id pub-id-type="pmid">27379018</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-18-02312">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanatsou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karst</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kortesidou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>van den Akker</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>den Blaauwen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Seckl</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Krugers</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Joels</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Overexpression of Mineralocorticoid Receptors in the Mouse Forebrain Partly Alleviates the Effects of Chronic Early Life Stress on Spatial Memory, Neurogenesis and Synaptic Function in the Dentate Gyrus</article-title>
<source/>Front. Cell. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>132</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00132</pub-id>
<pub-id pub-id-type="pmid">28611594</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-18-02312">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anacker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cattaneo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Luoni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Musaelyan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zunszain</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Milanesi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rybka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cirulli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Thuret</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis</article-title>
<source/>Neuropsychopharmacology
          <year>2013</year>
<volume>38</volume>
<fpage>872</fpage>
<lpage>883</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2012.253</pub-id>
<pub-id pub-id-type="pmid">23303060</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-18-02312">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>B.S.</given-names>
</name>
</person-group>
<article-title>Dynamic plasticity: The role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>239</volume>
<fpage>214</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.08.034</pub-id>
<pub-id pub-id-type="pmid">22922121</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-18-02312">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kvetnansky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Post</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus</article-title>
<source/>J. Neurosci.
          <year>1995</year>
<volume>15</volume>
<fpage>1768</fpage>
<lpage>1777</lpage>
<pub-id pub-id-type="pmid">7891134</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-18-02312">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vellucci</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Parrott</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Mimmack</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Down-regulation of BDNF mRNA, with no effect on trkB or glucocorticoid receptor m RNAs, in the porcine hippocampus after acute dexamethasone treatment</article-title>
<source/>Res. Vet. Sci.
          <year>2001</year>
<volume>70</volume>
<fpage>157</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1053/rvsc.2001.0456</pub-id>
<pub-id pub-id-type="pmid">11356095</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-18-02312">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gourley</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Kedves</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Olausson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF</article-title>
<source/>Neuropsychopharmacology
          <year>2009</year>
<volume>34</volume>
<fpage>707</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2008.123</pub-id>
<pub-id pub-id-type="pmid">18719621</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-18-02312">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vaidya</surname>
<given-names>V.A.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid regulation of brain-derived neurotrophic factor: Relevance to hippocampal structural and functional plasticity</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>239</volume>
<fpage>196</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.08.065</pub-id>
<pub-id pub-id-type="pmid">22967840</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-18-02312">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodes</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Brookshire</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Hill-Smith</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Teegarden</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Berton</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lucki</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Strain differences in the effects of chronic corticosterone exposure in the hippocampus</article-title>
<source/>Neuroscience
          <year>2012</year>
<volume>222</volume>
<fpage>269</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.06.017</pub-id>
<pub-id pub-id-type="pmid">22735575</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-18-02312">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heber-Katz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Leferovich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bedelbaeva</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gourevitch</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The scarless heart and the MRL mouse</article-title>
<source/>Philos. Trans. R. Soc. Lond. B Biol. Sci.
          <year>2004</year>
<volume>359</volume>
<fpage>785</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2004.1468</pub-id>
<pub-id pub-id-type="pmid">15293806</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-18-02312">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balu</surname>
<given-names>D.T.</given-names>
</name>
</person-group>
<article-title>Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of acute and chronic antidepressant treatments</article-title>
<source/>Exp. Clin. Psychopharmacol.
          <year>2010</year>
<volume>18</volume>
<fpage>71</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1037/a0017295</pub-id>
<pub-id pub-id-type="pmid">20158296</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-18-02312">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lombès</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Le Menuet</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells</article-title>
<source/>Mol. Brain
          <year>2017</year>
<volume>10</volume>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-017-0295-x</pub-id>
<pub-id pub-id-type="pmid">28403881</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-18-02312">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asadi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hedman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Widén</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zilliacus</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Wikström</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>FMS-like tyrosine kinase 3 interacts with the glucocorticoid receptor complex and affects glucocorticoid dependent signaling</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2008</year>
<volume>368</volume>
<fpage>569</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2008.01.146</pub-id>
<pub-id pub-id-type="pmid">18261979</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-18-02312">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1</article-title>
<source/>Cardiovasc. Res.
          <year>2011</year>
<volume>89</volume>
<fpage>419</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1093/cvr/cvq300</pub-id>
<pub-id pub-id-type="pmid">20855522</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-18-02312">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kumamaru</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yagasaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>647</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0800888106</pub-id>
<pub-id pub-id-type="pmid">19126684</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-18-02312">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arango-Lievano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jeanneteau</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Timing and crosstalk of glucocorticoid signaling with cytokines, neurotransmitters and growth factors</article-title>
<source/>Pharmacol. Res.
          <year>2016</year>
<volume>113</volume>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2016.08.005</pub-id>
<pub-id pub-id-type="pmid">27498156</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-18-02312">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GR-dependent signaling pathway</article-title>
<source/>Neurochem. Int.
          <year>2013</year>
<volume>62</volume>
<fpage>92</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2012.09.016</pub-id>
<pub-id pub-id-type="pmid">23063465</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-18-02312">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Bambah-Mukku</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pollonini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alberini</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidation</article-title>
<source/>Nat. Neurosci.
          <year>2012</year>
<volume>15</volume>
<fpage>1707</fpage>
<lpage>1714</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3266</pub-id>
<pub-id pub-id-type="pmid">23160045</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-18-02312">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Valverde</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Federoff</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Geller</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Hefti</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons</article-title>
<source/>Mol. Cell. Neurosci.
          <year>1996</year>
<volume>7</volume>
<fpage>222</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.1996.0017</pub-id>
<pub-id pub-id-type="pmid">8726105</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-18-02312">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farhadi</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Mowla</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Petrecca</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Seidah</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brainderived neurotrophic factor</article-title>
<source/>J. Neurosci.
          <year>2000</year>
<volume>20</volume>
<fpage>4059</fpage>
<lpage>4068</lpage>
<pub-id pub-id-type="pmid">10818141</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-18-02312">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egan</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Callicott</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Kolachana</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zaitsev</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gold</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function</article-title>
<source/>Cell
          <year>2003</year>
<volume>112</volume>
<fpage>257</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00035-7</pub-id>
<pub-id pub-id-type="pmid">12553913</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-18-02312">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kohara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsumoto</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Difference in trafficking of brain-derived neurotrophic factor between axons and dendrites of cortical neurons, revealed by live-cell imaging</article-title>
<source/>BMC Neurosci.
          <year>2005</year>
<volume>6</volume>
<elocation-id>42</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2202-6-42</pub-id>
<pub-id pub-id-type="pmid">15969745</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-18-02312">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Cawley</surname>
<given-names>N.X.</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>Y.P.</given-names>
</name>
</person-group>
<article-title>A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons</article-title>
<source/>Mol. Cell. Neurosci.
          <year>2008</year>
<volume>39</volume>
<fpage>63</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2008.05.016</pub-id>
<pub-id pub-id-type="pmid">18573344</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-18-02312">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwinter</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mafi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Dynactin regulates bidirectional transport of dense-core vesicles in the axon and dendrites of cultured hippocampal neurons</article-title>
<source/>Neuroscience
          <year>2009</year>
<volume>162</volume>
<fpage>1001</fpage>
<lpage>1010</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.05.038</pub-id>
<pub-id pub-id-type="pmid">19497353</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-18-02312">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harjes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wanker</surname>
<given-names>E.E.</given-names>
</name>
</person-group>
<article-title>The hunt for huntingtin function: Interaction partners tell many different stories</article-title>
<source/>Trends Biochem. Sci.
          <year>2003</year>
<volume>28</volume>
<fpage>425</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1016/S0968-0004(03)00168-3</pub-id>
<pub-id pub-id-type="pmid">12932731</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-18-02312">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Gutekunst</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Hersch</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.J.</given-names>
</name>
</person-group>
<article-title>Interaction of huntingtin-associated protein with dynactin P150Glued</article-title>
<source/>J. Neurosci.
          <year>1998</year>
<volume>18</volume>
<fpage>1261</fpage>
<lpage>1269</lpage>
<pub-id pub-id-type="pmid">9454836</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-18-02312">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGuire</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.J.</given-names>
</name>
</person-group>
<article-title>Interaction of Huntingtin-associated protein-1 with kinesin light chain: Implications in intracellular trafficking in neurons</article-title>
<source/>J. Biol. Chem.
          <year>2006</year>
<volume>281</volume>
<fpage>3552</fpage>
<lpage>3559</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M509806200</pub-id>
<pub-id pub-id-type="pmid">16339760</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-18-02312">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauthier</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Charrin</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Borrell-Pagès</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dompierre</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Rangone</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cordelières</surname>
<given-names>F.P.</given-names>
</name>
<name>
<surname>De Mey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Lessmann</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Humbert</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules</article-title>
<source/>Cell
          <year>2004</year>
<volume>118</volume>
<fpage>127</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2004.06.018</pub-id>
<pub-id pub-id-type="pmid">15242649</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-18-02312">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adachi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Numakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukuoka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Odaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Katanuma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ooshima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hohjoh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kunugi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid affects dendritic transport of BDNF-containing vesicles</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>12684</fpage>
<pub-id pub-id-type="doi">10.1038/srep12684</pub-id>
<pub-id pub-id-type="pmid">26239075</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-18-02312">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Schug</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brestelli</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Bochkis</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Kaestner</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptor-dependent gene regulatory networks</article-title>
<source/>PLoS Genet.
          <year>2005</year>
<volume>1</volume>
<elocation-id>e16</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.0010016</pub-id>
<pub-id pub-id-type="pmid">16110340</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-18-02312">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seifert</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eckenstaler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rönicke</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Leschik</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lutz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Reymann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lessmann</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Brigadski</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons</article-title>
<source/>Neural. Plast.
          <year>2016</year>
<fpage>4145708</fpage>
<pub-id pub-id-type="doi">10.1155/2016/4145708</pub-id>
<pub-id pub-id-type="pmid">26881108</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-18-02312">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Buijs</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer’s disease</article-title>
<source/>Br. J. Pharmacol.
          <year>2004</year>
<volume>143</volume>
<fpage>606</fpage>
<lpage>610</lpage>
<pub-id pub-id-type="doi">10.1038/sj.bjp.0705995</pub-id>
<pub-id pub-id-type="pmid">15466441</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-18-02312">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Garcia-Munoz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shepardson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brett</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Rowan</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Lemere</surname>
<given-names>C.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory</article-title>
<source/>Nat. Med.
          <year>2008</year>
<volume>14</volume>
<fpage>837</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="doi">10.1038/nm1782</pub-id>
<pub-id pub-id-type="pmid">18568035</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-18-02312">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roozendaal</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Stress and memory: Opposing effects of glucocorticoids on memory consolidation and memory retrieval</article-title>
<source/>Neurobiol. Learn. Mem.
          <year>2002</year>
<volume>78</volume>
<fpage>578</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1006/nlme.2002.4080</pub-id>
<pub-id pub-id-type="pmid">12559837</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-18-02312">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bekinschtein</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cammarota</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Katche</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Slipczuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rossato</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Goldin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Izquierdo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Medina</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>BDNF is essential to promote persistence of long-term memory storage</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>2711</fpage>
<lpage>2716</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0711863105</pub-id>
<pub-id pub-id-type="pmid">18263738</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-18-02312">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vyas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Tronche</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>O.F.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sotiropoulos</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration</article-title>
<source/>Neural. Plast.
          <year>2016</year>
<volume>2016</volume>
<fpage>6391686</fpage>
<pub-id pub-id-type="doi">10.1155/2016/6391686</pub-id>
<pub-id pub-id-type="pmid">27034847</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-18-02312">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rothman</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Herdener</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Camandola</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Texel</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Mughal</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Cong</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mattson</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress</article-title>
<source/>Neurobiol. Aging
          <year>2012</year>
<volume>33</volume>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.07.005</pub-id>
<pub-id pub-id-type="pmid">21855175</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-18-02312">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braun</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Kalinin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Feinstein</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer’s Disease</article-title>
<source/>ASN Neuro
          <year>2017</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1177/1759091417696161</pub-id>
<pub-id pub-id-type="pmid">28266222</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-18-02312">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerenu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Martisova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rantamäki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Gil-Bea</surname>
<given-names>F.J.</given-names>
</name>
</person-group>
<article-title>Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer’s neuropathology and cognitive deficits</article-title>
<source/>Biochim. Biophys. Acta
          <year>2017</year>
<volume>1863</volume>
<fpage>991</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2017.01.023</pub-id>
<pub-id pub-id-type="pmid">28132883</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-18-02312">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hempstead</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions</article-title>
<source/>Trans. Am. Clin. Climatol. Assoc.
          <year>2015</year>
<volume>126</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">26330656</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-18-02312">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Manaph</surname>
<given-names>N.P.A.</given-names>
</name>
<name>
<surname>Bobrovskaya</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.F.</given-names>
</name>
</person-group>
<article-title>ProBDNF inhibits proliferation, migration and differentiation of mouse neural stem cells</article-title>
<source/>Brain Res.
          <year>2017</year>
<volume>1668</volume>
<fpage>46</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2017.05.013</pub-id>
<pub-id pub-id-type="pmid">28528122</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-18-02312">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lucassen</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis—What do we need to know?</article-title>
<source/>Front. Neuroendocrinol.
          <year>2016</year>
<volume>41</volume>
<fpage>153</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.yfrne.2015.12.001</pub-id>
<pub-id pub-id-type="pmid">26746105</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-18-02312">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrero</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Estrada</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maatouk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vyas</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Inflammation in Parkinson’s disease: Role of glucocorticoids</article-title>
<source/>Front. Neuroanat.
          <year>2015</year>
<volume>9</volume>
<fpage>32</fpage>
<pub-id pub-id-type="doi">10.3389/fnana.2015.00032</pub-id>
<pub-id pub-id-type="pmid">25883554</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-18-02312">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numakawa</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Possible protective action of neurotrophic factors and natural compounds against common neurodegenerative diseases</article-title>
<source/>Neural Regen. Res.
          <year>2014</year>
<volume>9</volume>
<fpage>1506</fpage>
<lpage>1508</lpage>
<pub-id pub-id-type="doi">10.4103/1673-5374.139474</pub-id>
<pub-id pub-id-type="pmid">25317165</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-18-02312">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martínez-Levy</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rodríguez-Pineda</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Alonso-Vanegas</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Nani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Buentello-García</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Briones-Velasco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>San-Juan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cienfuegos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cruz-Fuentes</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Increased Expression of Brain-Derived Neurotrophic Factor Transcripts I and VI, cAMP Response Element Binding, and Glucocorticoid Receptor in the Cortex of Patients with Temporal Lobe Epilepsy</article-title>
<source/>Mol. Neurobiol.
          <year>2017</year>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-017-0597-0</pub-id>
<pub-id pub-id-type="pmid">26708209</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-18-02312-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>A proposed model for microtubule-dependent vesicular transport of brain-derived neurotrophic factor (BDNF) protein. Huntingtin (htt) and htt-associated protein 1 (HAP1) stabilize the linkage between dynein and dynactin complex. Dynein functions as a motor protein and dynactin complex attaches BDNF-containing vesicles to the motor protein complex with p150<sup>Glued</sup> protein.</p>
</caption>
<graphic xlink:href="ijms-18-02312-g001"></graphic>
</fig>
<fig id="ijms-18-02312-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>(<bold>A</bold>) Vesicular distribution of BDNF-GFP expressed in cultured cortical neuron obtained from rat brain (12 days in vitro). BDNF-containing vesicles are transported both in dendrites (MAP2-positive neurites) and axon (MAP2-negative one); (<bold>B</bold>) A magnified image of the white square region of A; (<bold>C</bold>) The effect of GCs on the proportion of the state of BDNF-vesicle transport. Time-laps imaging of BDNF-GFP revealed that more than 50% of BDNF-containing vesicles were not transported (stationary) in dendrites in the normal condition while DEX (an agonist for GR, 1 µM) increased and decreased the proportion of transported (&gt;10 µm) and stationary vesicles, respectively. Data represent mean ± SE. Data was obtained from 7 (control) to 6 (DEX) neurons in four independent culture preparations including 388 and 302 vesicles, respectively. Statistical significance was evaluated by student’s <italic>t</italic>-test. Please see details in [<xref ref-type="bibr" rid="B78-ijms-18-02312">78</xref>].</p>
</caption>
<graphic xlink:href="ijms-18-02312-g002"></graphic>
</fig>
<fig id="ijms-18-02312-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Chronic glucocorticoids (GCs) stress, which stimulates glucocorticoid receptor (GR) activation, causes downregulation of expression/function of BDNF. Because BDNF has pivotal roles in supporting neurogenesis and preventing neurodegeneration, it is possible that excess GCs functions as a negative factor in neurogenesis and a risk factor for the development/progression of neurodegenerative pathologies.</p>
</caption>
<graphic xlink:href="ijms-18-02312-g003"></graphic>
</fig>
<table-wrap id="ijms-18-02312-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-18-02312-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Actions of GCs on neurogenesis and BDNF expression.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">In Vivo/In Vitro</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Drug Application or Animals</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Neurogenesis/BDNF</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult mice hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GR(+/−) mice</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">BDNF ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ridder et al. [<xref ref-type="bibr" rid="B40-ijms-18-02312">40</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult mice hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GR nestin-cre −/− mice</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">proliferation -</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gass et al. [<xref ref-type="bibr" rid="B43-ijms-18-02312">43</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rat embryonic neural progenitor cells (in vitro)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CORT (10 µM 3–10 days)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">proliferation -differentiation ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Odaka et al. [<xref ref-type="bibr" rid="B44-ijms-18-02312">44</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Human hippocampal progenitor cell line (in vitro)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cortisol (10 µM 3–10 days)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">proliferation ↓ differentiation ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Anacker et al. [<xref ref-type="bibr" rid="B46-ijms-18-02312">46</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult mice hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CORT (40 mg/kg daily injection for 8 weeks)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">proliferation ↓ differentiation ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Zhang et al. [<xref ref-type="bibr" rid="B47-ijms-18-02312">47</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult rat hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CORT (40 mg/kg weakly injection for 3 weeks)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">differentiation ↓ maturation ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lussier et al. [<xref ref-type="bibr" rid="B48-ijms-18-02312">48</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult female rat hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CORT (40 mg/kg daily injection for 23 days)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">differentiation ↓ *</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kott et al. [<xref ref-type="bibr" rid="B49-ijms-18-02312">49</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult rat hippocampal progenitor cells (in vitro)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fludrocortisone (1 μM 24 h)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">survival ↓ proliferation ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gesmundo et al. [<xref ref-type="bibr" rid="B50-ijms-18-02312">50</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult C57BL/6J mice hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CORT (36 mg/kg/day for 7 days by pellet implantation)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">proliferation ↓ BDNF ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hodes et al. [<xref ref-type="bibr" rid="B58-ijms-18-02312">58</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult MRL/MpJ mice hippocampus (in vivo)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CORT (27 mg/kg/day for 7 days by pellet implantation)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">proliferation - BDNF -</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hodes et al. [<xref ref-type="bibr" rid="B58-ijms-18-02312">58</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">mouse embryonic stem cells (in vitro)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ginsenoside Rg1 (10 μM, 14 days)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">differentiation ↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Wu et al. [<xref ref-type="bibr" rid="B66-ijms-18-02312">66</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>↑ increase; ↓ decrease; - no change; * Subcutaneous injection vs. pellet implantation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>